Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
Clicks: 279
ID: 6666
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
70.8
/100
279 views
230 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #59 of 194 articles by views in journal of hepatocellular carcinoma
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 194 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Emerging role of Toll-like receptor 4 in hepatocellular carcinoma Jing Yang,1 Min Li,2 Qi Chang Zheng2 1Department of First General Surgery, Gansu Provincial Hospital, Lanzhou, 2Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China Abstract: Toll-like receptor (TLR) signaling has been implicated in inflammatory-related cancers. The upregulation of TLR signaling in hepatocellular carcinoma (HCC) suggests that it may play an essential role in the prognosis of chronic and inflammatory diseases that ultimately culminate in HCC. Here, we provide evidence about the involvement of the TLR pathway in the initiation, progression, and metastasis of HCC. The differential expression of TLR in epithelial cells has also been discussed. In particular, we emphasize the physiological role of TLR4 in the development and pathogenesis of HCC and propose novel and promising approaches for HCC therapeutics with the aid of TLR ligands. Keywords: hepatocarcinogenesis, inflammation, signal pathway, immune therapy
| Reference Key |
jing2015emergingjournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jing Yang;Min Li;Qi Chang Zheng and |
| Journal | journal of hepatocellular carcinoma |
| Year | 2015 |
| DOI |
10.2147/JHC.S44515
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.